The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial (Q40247162)
Jump to navigation
Jump to search
scientific article published on 30 January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial |
scientific article published on 30 January 2007 |
Statements
1 reference
The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial (English)
1 reference
1 reference
Greg Gamble
1 reference
Andrew Grey
1 reference
Diana Wattie
1 reference
James Davidson
1 reference
30 January 2007
1 reference
1 reference
Identifiers
1 reference